Process information
| Key Data Set Information | |
| Location | HAZ-ZJ-CN |
| Reference year | 2022 |
| Name |
|
| Use advice for data set | Users should ensure the data selected corresponds accurately to the production process described, including fermentation and super-resistant production techniques. The life cycle inventory data should reflect the environmental impacts of the seed culture, fermentation, refining, and drying stages. Special attention must be given to the reliability of the company-provided monitoring data, and it should be verified if it aligns with established emissions and waste treatment standards for pharmaceutical manufacturing. |
| Technical purpose of product or process | Moxifloxacin Active Pharmaceutical Ingredient (API) is produced for use as a broad-spectrum antibiotic in the pharmaceutical industry. It is specifically used to manufacture medications against bacterial infections in healthcare settings. |
| Classification |
Class name
:
Hierarchy level
|
| General comment on data set | Moxifloxacin Active Pharmaceutical Ingredient (API) is produced for use as a broad-spectrum antibiotic in the pharmaceutical industry. It is specifically used to manufacture medications against bacterial infections in healthcare settings. |
| Copyright | No |
| Owner of data set | |
| Quantitative reference | |
| Reference flow(s) | |
| Time representativeness | |
| Time representativeness description | Environmental impact assessment report publication date |
| Technological representativeness | |
| Technology description including background system | Moxifloxacin is produced using fermentation and super-resistant production techniques. The production process includes seed culture, fermentation, refining, drying, and other steps. |
| Flow diagram(s) or picture(s) | |
Modelling and validation
Administrative information
Inputs and Outputs